Shilpa Medicare enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


17,133	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
41.3	41.3	26.0	30.2	21.3
—	—	−8.5	−8.7	−8.9
658	658	586	936	796
17,749	—	—	—	—
617	617	560	905	774
₹907.43	—	—	—	—

3,249	3,249	2,950	2,736	2,570
20.3%	20.3%	19.9%	34.2%	31.0%
0.04×	—	—	—	—

10.55×	—	—	—	—
37.09×	—	—	—	—
50.35×	—	—	—	—
1,682	1,539	1,286	1,152	1,050
479	435	317	244	102
353	315	204	137	6.8
—	342	132	135	226
−28.5	−28.5	−111	−49.2	−46.4
—	−36.8	−139	−84.2	−58.7
—	371	244	185	273

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHILPAMED₹875.90

Shilpa Medicare Ltd.

· Pharma & Health

₹ CrorePeersNATCOPHARM SPARC STAR RUBICON SUPRIYA THYROCARE VIYASH PARKHOSPSMcap ₹17,133 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	17,132.6
- Cash, Equiv & ST Investments	21.3	30.2	26.0	41.3	41.3
+ Minority Interest	-8.9	-8.7	-8.5	—	—
+ Total Debt	795.7	935.6	586.4	658.0	658.0
Enterprise Value	—	—	—	—	17,749.3
Net Debt (memo)	774.4	905.4	560.4	616.7	616.7
EV per Share	—	—	—	—	907.43

Total Capital	2,570.1	2,735.5	2,950.1	3,249.2	3,249.2
Total Debt/Total Capital	30.96	34.20	19.88	20.25	20.25
Total Debt/EV	—	—	—	—	0.04

EV/Sales	—	—	—	—	10.55
EV/EBITDA	—	—	—	—	37.09
EV/EBIT	—	—	—	—	50.35
Reference Items — Trailing FY Values
Sales	1,050.1	1,151.6	1,286.4	1,538.9	1,682.5
EBITDA	102.3	244.5	317.0	434.7	478.6
EBIT	6.8	136.6	204.1	315.0	352.5
Operating Cash Flow	226.2	135.3	132.2	342.2	—
Free Cash Flow	-46.4	-49.2	-111.5	-28.5	-28.5
FCFF (free cash flow to the firm)	-58.7	-84.2	-138.8	-36.8	—
Capital Expenditure	272.5	184.6	243.6	370.6	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.